Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M in funding.
The round was led by Wittington Ventures and Great Point Ventures, with participation from existing investors, including DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures. As a part of the round, Shoppers Drug Mart, Canada’s largest pharmacy, joined Truvian as a commercial partner.
The company intends to use the funds to secure US Food and Drug Administration (FDA) clearance for its blood testing platform.
Led by CEO Jay Srinivasan, Truvian provides an automated benchtop platform that offers routine blood tests to be performed in clinics, doctor’s offices and pharmacies. To date, Its integrated platform has been evaluated on more than 50,000 samples across 5,000 donors while achieving a platform run reliability rate of greater than 98%. The company has also scaled its instrument and consumable manufacturing capabilities to initiate its clinical trials and early partner access programs.
FinSMEs
16/07/2024